Adlai Nortye ANL
NASDAQ ANL
$9.96 -1.19 (-10.67%)
At close: Nov 10, 2026 · 4:00 PM EST

Adlai Nortye (ANL) Current Assets (2022 - 2026)

Updated

Adlai Nortye's Current Assets was $240.88 million in Q2 2026, up 267.9% from $65.48 million a year earlier.

Analysis

Adlai Nortye (ANL) Current Assets (2022 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Adlai Nortye came in at $26.89 million, down 58.0% from FY2024.

  • Current Assets shows a three-year compound annual growth rate of -26.0% (FY2022 to FY2025).
  • In earlier years, Current Assets was $64.06 million in FY2024 (-36.7%), $101.2 million in FY2023 (+52.6%) and $66.3 million in FY2022.
  • Compared with a year earlier, Current Assets was higher in 1 of the last four quarters, with growth averaging 34.6%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 56.35 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 37.48 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 27.97 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 16.55 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 45.01 Bn
10 Adlai Nortye 342.45 Mn 139.24 Mn - 26.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 240.88 Mn
Dec 31, 2025 26.89 Mn
Jun 30, 2025 65.48 Mn
Dec 31, 2024 64.06 Mn
Jun 30, 2024 100.28 Mn
Dec 31, 2023 101.20 Mn
Dec 31, 2022 66.30 Mn
API Access

Adlai Nortye Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ANL&period=max&api_key=YOUR_API_KEY